Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that new data from its research ...

One way to cope with cuts in HIV prevention funding is to continue to push to increase the number of people who self-test for HIV instead of getting tested at a clinic or hospital, experts at a series ...

8 July 2025 (Kigali, Rwanda) – IAS 2025, the 13th IAS Conference on HIV Science, taking place in Kigali, Rwanda, and virtually from 13 to 17 July, will feature an array of studies that address the ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

The Retention Riddle: Tackling the Toughest Barrier to Ending HIV: This session will explore proven strategies for ensuring people living with HIV stay connected to care and treatment services, a ...

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...

A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...

Experts are celebrating a breakthrough in HIV prevention. Doctors say it could mean we're one step closer to eradicating the ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Gilead researchers and collaborators will present new Phase 3 ...